Quest Diagnostics Inc
(MEX:DGX)
MXN
2458.05
0 (0%)
Market Cap: 331.36 Bil
Enterprise Value: 425.03 Bil
PE Ratio: 20.66
PB Ratio: 2.57
GF Score: 87/100 Quest Diagnostics Inc at Barclays Global Healthcare Conference Transcript
Mar 12, 2019 / 02:15PM GMT
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
Okay. Well, thank you. Good morning. Our third presentation in the morning with Quest CFO, Mark Guinan; as well as Head of Investor Relations, Shawn Bevec, here from Quest and I'm Jack Meehan, the Life Science Tools and Diagnostics analyst.
We're going to start with some audience response questions. So we'll kick those off. Please use the BlackBerry device in front of you.
Questions & Answers
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
Question #1. What do you view as Quest's organic growth profile over the next 3 years? We're testing who went to the Analyst Day.
Mark J. Guinan;
Quest Diagnostics Incorporated - Executive VP & CFO
As we provided at the Analyst Day in November, we gave a 4-year outlook, as you recall, Jack, and talked about 3% to 5% overall growth with about 200 basis points coming from M&A. So that would imply a low single digit.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot